Digital Atrial Fibrillation Screening to Prevent Stroke in Older Adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This population-based, siteless randomized trial tests whether a smartphone app using photoplethysmography can identify atrial fibrillation and prompt management changes to prevent strokes. Participants aged 65 and older are randomized to the digital intervention or usual care, with confirmatory 7-day ECG patch monitoring if AF is suspected. The primary outcome is hospitalization for stroke of any type within 48 months, with secondary outcomes including mortality, cardiovascular events, bleeding, and health-care utilization. The study is embedded in the Austrian public health system and uses a brand-independent AF screening pathway, with digital education and telehealth support for those in the intervention arm.

Why it matters

Who can join: the full rules

Inclusion Criteria

1. Age ≥ 65 years
2. Policyholder in Austria (active unique social insurance number)
3. Written electronic informed consent Exclusion Criteria

a) Currently treated with oral anticoagulation b) Cardiac implanted electronic device (CIED)

Where it's running

• Department of Internal Medicine III, Medical University Innsbruck
  Innsbruck, Tyrol, Austria Recruiting

Study contacts

• Principal investigator: Sebastian J Reinstadler, MD, PhD — Medical University Innsbruck
• Study coordinator: Sebastian J Reinstadler, MD, PhD
• Email: sebastian-johannes.reinstadler@i-med.ac.at
• Phone: +4351250425621

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Deep phenotyping to explore recovery in young adults after stroke

  This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

  Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

• Assessing stroke risk in patients with newly diagnosed atrial fibrillation

  This study is testing how to identify stroke risk in people who have just been diagnosed with atrial fibrillation to see who might need blood-thinning medication to prevent strokes.

  Recruiting University of Southern Denmark · Esbjerg, Region Syddanmark · NCT06949319

• Stem cell therapy for chronic stroke recovery

  This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.

  Recruiting Phase 2 Hokkaido University Hospital · Sapporo, Hokkaido · NCT06752720

• AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals

  This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.

  Recruiting at 2 sites Hospital Universitari Vall d'Hebron Research Institute · Leuven and 6 other locations · NCT07924371

• Web-based therapy using action observation and mirror therapy for arm weakness after stroke

  This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.

  Recruiting Chang Gung Memorial Hospital · Taoyuan · NCT07921108

• Remote Ischaemic Conditioning for Fatigue After Stroke 2

  Aat least 12 weeks after stroke, adults with post-stroke fatigue will try a simple hand-arm cuff treatment at home to see if it helps reduce fatigue.

  Recruiting Phase 2 Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT07914647

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.